Cadonilimab combined with taxane and cisplatin as the first-line treatment of advanced esophageal squamous cell carcinoma: an open-label, multicenter phase II trial

Authors

Institutions

Publication Details

Journal
Journal for ImmunoTherapy of Cancer
Published
2025-10-01
DOI
https://doi.org/10.1136/jitc-2025-012869
Citations
2
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
4.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cadonilimab combined with taxane and cisplatin as the first-line treatment of advanced esophageal squamous cell carcinoma: an open-label, multicenter phase II trial

Yijia Guo, Bo Zhang, Mudan Yang, Jing Gao et al.
2 citations
Journal for ImmunoTherapy of Cancer
Esophageal Cancer Research and Treatment
4.01
article

Cadonilimab combined with taxane and cisplatin as the first-line treatment of advanced esophageal squamous cell carcinoma: an open-label, multicenter phase II trial

Yijia Guo, Bo Zhang, Mudan Yang, Jing Gao, Siying Guo, Ying Wang, Jing Huang, Wang Qu, Yun Liu
article en
2 citations

Abstract

No abstract available for this paper.
Journal for ImmunoTherapy of CancerVol. 13(10)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Chinese PLA General Hospital (CN), Shanxi Provincial Cancer Hospital (CN)
Openalex Percentile: Top 6%
Esophageal Cancer Research and Treatment
4.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.